|
|
1. 十字文子, 小林茂俊, 伊東繁, 菅原由人, 狩野博嗣, 安枝浩, et al. アトピー性皮膚炎におけるスギ減感作療法. アレルギー2003 2003.11;52(11):1081-8.
2. 尾藤利憲, 福永淳, 大橋明子, 堀川達弥, 市橋正光, 錦織千佳子. 自己の汗希釈液を用いたアトピー性皮膚炎患者に対する減感作療法. 日本皮膚アレルギー学会雑誌2003 2003.09;11(3):122-7.
3. Oosting AJ, de Bruin-Weller MS, Terreehorst I, Tempels-Pavlica Z, Aalberse RC, de Monchy JG, et al. Effect of mattress encasings on atopic dermatitis outcome measures in a double-blind, placebo-controlled study: the Dutch mite avoidance study. J Allergy Clin Immunol2002 Sep;110(3):500-6.
4. Koopman LP, van Strien RT, Kerkhof M, Wijga A, Smit HA, de Jongste JC, et al. Placebo-controlled trial of house dust mite-impermeable mattress covers: effect on symptoms in early childhood. Am J Respir Crit Care Med2002 Aug 1;166(3):307-13.
5. Gutgesell C, Heise S, Seubert S, Seubert A, Domhof S, Brunner E, et al. Double-blind placebo-controlled house dust mite control measures in adult patients with atopic dermatitis. Br J Dermatol2001 Jul;145(1):70-4.
6. Holm L, Bengtsson A, van Hage-Hamsten M, Ohman S, Scheynius A. Effectiveness of occlusive bedding in the treatment of atopic dermatitis--a placebo-controlled trial of 12 months' duration. Allergy2001 Feb;56(2):152-8.
7. Ricci G, Patrizi A, Specchia F, Menna L, Bottau P, D'Angelo V, et al. Effect of house dust mite avoidance measures in children with atopic dermatitis. Br J Dermatol2000 Aug;143(2):379-84.
8. Mastrandrea F, Serio G, Minelli M, Minardi A, Scarcia G, Coradduzza G, et al. Specific sublingual immunotherapy in atopic dermatitis. Results of a 6-year follow-up of 35 consecutive patients. Allergol Immunopathol (Madr)2000 Mar-Apr;28(2):54-62.
9. Friedmann PS, Tan BB. Mite elimination--clinical effect on eczema. Allergy1998;53(48 Suppl):97-100.
10. Tan BB, Weald D, Strickland I, Friedmann PS. Double-blind controlled trial of effect of housedust-mite allergen avoidance on atopic dermatitis. Lancet 1996 Jan 6;347(8993):15-8.
11.vGalli E, Chini L, Nardi S, Benincori N, Panei P, Fraioli G, et al. Use of a specific oral hyposensitization therapy to Dermatophagoides pteronyssinus in children with atopic dermatitis. Allergol Immunopathol (Madr)1994 Jan-Feb;22(1):18-22.
12. Sanda T, Yasue T, Oohashi M, Yasue A. Effectiveness of house dust-mite allergen avoidance through clean room therapy in patients with atopic dermatitis. J Allergy Clin Immunol1992 Mar;89(3):653-7.
13. 宮内恵, 平林徹, 徳田安章. アトピー性皮膚炎の治療 減感作療法 特にMillerの方法を応用した特異的減感作療法について. 治療学. [原著論文]1992.08;26(8):979-82.
14. Glover MT, Atherton DJ. A double-blind controlled trial of hyposensitization to Dermatophagoides pteronyssinus in children with atopic eczema. Clin Exp Allergy1992 Apr;22(4):440-6.
15. Nahm DH, Lee ES, Park HJ, Kim HA, Choi GS, Jeon SY. Treatment of atopic dermatitis with a combination of allergen-specific immunotherapy and a histamine-immunoglobulin complex. Int Arch Allergy Immunol2008;146(3):235-40.
16. Pajno GB, Caminiti L, Vita D, Barberio G, Salzano G, Lombardo F, et al. Sublingual immunotherapy in mite-sensitized children with atopic dermatitis: a randomized, double-blind, placebo-controlled study. J Allergy Clin Immunol2007;120(1):164-70.
17. Arshad SH, Bateman B, Sadeghnejad A, Gant C, Matthews SM. Prevention of allergic disease during childhood by allergen avoidance: the Isle of Wight prevention study. J Allergy Clin Immunol2007;119(2):307-13.
18. Cadario G, Galluccio AG, Pezza M, Appino A, Milani M, Pecora S, et al. Sublingual immunotherapy efficacy in patients with atopic dermatitis and house dust mites sensitivity: a prospective pilot study. Curr Med Res Opin2007;23(10):2503-6.
19. Corver K, Kerkhof M, Brussee JE, Brunekreef B, van Strien RT, Vos AP, et al. House dust mite allergen reduction and allergy at 4 yr: follow up of the PIAMA-study. Pediatr Allergy Immunol2006;17(5):329-36.
20. Werfel T, Breuer K, Rueff F, Przybilla B, Worm M, Grewe M, et al. Usefulness of specific immunotherapy in patients with atopic dermatitis and allergic sensitization to house dust mites: a multi-centre, randomized, dose-response study. Allergy2006;61(2):202-5. |
|
